Neelim للاستشارات الصحية
Neelim

QCHP Haematology & Oncology exam questions

Anaemias, haemostasis, haematological and solid tumours, chemotherapy.

For SCFHS · QCHPPass mark SCFHS 65% · QCHP 65%From 3 papers · ~150 Qs each
AED 319one-time
About a third of one exam fee
Request this question bank

Tell us your authority and we send the bank for that exam, usually the same day.

Or sit 12 questions free first →

Every regulator: format, pass marks and fees for all GCC licensing exams, each from the regulator's own documents.

The Haematology & Oncology exam at a glance

SCFHS (Saudi Arabia) publishes a Haematology & Oncology exam of 200 MCQs in 240 minutes with a 65% pass mark; QCHP (Qatar) publishes a Haematology & Oncology exam of 150 MCQs in 3 hours with a 65% pass mark. DOH licenses the title without a published written exam (credential review, interview or an unpublished assessment). DHA, MOHAP, SHA, NHRA, OMSB, Kuwait MOH publish no exam for this title.

SCFHS · Saudi Arabia
Saudi Classification Examination - Hematology and Oncology
200 MCQs in 240 minutes · pass mark 65% · checked October 2026
QCHP · Qatar
Specialist Haematology and Oncology
150 MCQs in 3 hours · pass mark 65% · checked September 2026

From each regulator's own exam documents. Every other regulator is in the full GCC table.

Try two questions from this bank

Original questions from the bank - pick an answer to see the rationale and reference.

Q1Haemoglobinopathies and Transfusion Medicine

Ten minutes into a red cell transfusion, a patient develops fever, rigors, loin pain and hypotension. What is the first action?

Choose an answer to see the rationale.

Q2Haemostasis and Thrombosis

A patient taking dabigatran presents with a large intracranial haemorrhage. Which specific reversal agent should be given?

Choose an answer to see the rationale.

Not sure where you stand? Sit 12 of these questions free, timed at real exam pace, and see which domains you are weakest in.

Take the free mock exam →

Liked those? The full bank has 450 questions at this standard - every one with a rationale and a reference.

Get the full bank - AED 319

What's inside

  • ✓3 to 6 full-length papers (~150 Q each)
  • ✓No question repeated between papers
  • ✓Four options, one unambiguous best answer
  • ✓A full rationale on every question
  • ✓A real guideline or textbook reference
  • ✓Every sub-topic in the published blueprint
  • ✓Researched by Neelim's exam research team

The Haematology & Oncology exam in every GCC country

Haematology & Oncology licensing exam in every GCC country
RegulatorExamFormatPass markFee per attempt
SCFHS
Kingdom of Saudi Arabia
Practise →
Saudi Classification Examination - Hematology and Oncology
200 MCQs in 240 minutes65%Not published
QCHP
State of Qatar
Practise →
Specialist Haematology and Oncology
150 MCQs in 3 hours65%Not published
No exam published for this title
Not in the DHA CBT list; DHA's guideline assesses licensed titles that are not listed by oral
Not publishedNot publishedNot published
DOH
Abu Dhabi, Al Ain and Al Dhafra
Practise →
No written exam published
Oral assessment, 45-60 minutes; no written exam (DOH Licensing Procedure Manual 2024)
Panel / reviewNot publishedNot published
MOHAP
Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah
Practise →
No exam published for this title
MOHAP publishes no exam for this title that we could find; check with MOHAP
Not publishedNot publishedNot published
SHA
Emirate of Sharjah
Practise →
No exam published for this title
SHA publishes no exam for this title that we could find; check with SHA
Not publishedNot publishedNot published
NHRA
Kingdom of Bahrain
Practise →
No exam published for this title
NHRA publishes no exam for this title that we could find; check with NHRA
Not publishedNot publishedNot published
OMSB
Sultanate of Oman
Practise →
No exam published for this title
No OMSB exam published for this title; check with OMSB
Not publishedNot publishedNot published
Kuwait MOH
State of Kuwait
Practise →
No exam published for this title
Kuwait MOH publishes no exam for this title; check with the MOH
Not publishedNot publishedNot published

Highlighted rows publish figures for this exact Haematology & Oncology exam; the others show the regulator's general rules.

From each regulator's own exam pages; anything a regulator does not publish says so. Assessment mode also depends on your licence title, so confirm your route on your eligibility notice.

Try 15 free Haematology & Oncology questions with answersDifferent from the samples on this page - each with a full explanationStart →

What the Haematology & Oncology exam covers

The published blueprint for this exam breaks into 9 domains and 64 testable sub-topics. Our bank covers every one of them - here is the full map, so you can see exactly what you are expected to know.

Red Cell Disorders and Anaemias~14%7 topics
  • Iron deficiency and anaemia of inflammation
  • Vitamin B12 and folate deficiency
  • Autoimmune haemolytic anaemia: warm and cold
  • Paroxysmal nocturnal haemoglobinuria
  • Aplastic anaemia and pure red cell aplasia
  • Hereditary spherocytosis and G6PD deficiency
  • Interpretation of the blood film and reticulocyte count
Haemoglobinopathies and Transfusion Medicine~12%7 topics
  • Sickle cell disease: crises, acute chest syndrome and hydroxyurea
  • Thalassaemia trait and major: diagnosis and iron overload
  • ABO incompatibility and acute haemolytic reactions
  • TRALI and TACO
  • Irradiated and CMV-safe components
  • Patient blood management and transfusion thresholds
  • Premarital and antenatal haemoglobinopathy screening
Haemostasis and Thrombosis~14%8 topics
  • Interpretation of PT, APTT and mixing studies
  • Haemophilia A and B
  • Von Willebrand disease
  • Heparin-induced thrombocytopenia
  • Thrombotic thrombocytopenic purpura and other TMAs
  • Venous thromboembolism treatment and duration
  • Antiphospholipid syndrome
  • Anticoagulant reversal
Myeloid Malignancies~10%7 topics
  • Acute myeloid leukaemia: classification and risk
  • Acute promyelocytic leukaemia and differentiation syndrome
  • Chronic myeloid leukaemia and TKI monitoring
  • Polycythaemia vera, essential thrombocythaemia and myelofibrosis
  • Myelodysplastic neoplasms
  • Acute lymphoblastic leukaemia in adults
  • Molecular markers in myeloid disease
Lymphoid Malignancies and Plasma Cell Disorders~12%7 topics
  • Hodgkin lymphoma: pathology and staging
  • Diffuse large B-cell lymphoma and anti-CD20 therapy
  • Burkitt and other high-grade lymphomas
  • Chronic lymphocytic leukaemia
  • Follicular and other indolent lymphomas
  • Multiple myeloma: diagnostic criteria and treatment
  • MGUS and amyloidosis
Solid Tumour Oncology~16%9 topics
  • Breast cancer: receptor status and adjuvant therapy
  • HER2-targeted therapy and cardiac monitoring
  • Colorectal cancer: RAS status and anti-EGFR therapy
  • Lung cancer: driver mutations and targeted therapy
  • Germ cell tumours and tumour markers
  • Ovarian and gynaecological cancers
  • Prostate cancer
  • Head and neck and upper GI cancers
  • TNM staging and performance status
Systemic Anticancer Therapy and Supportive Care~10%7 topics
  • Neutropenic sepsis management
  • Chemotherapy toxicities: anthracyclines, platinum, methotrexate
  • Antiemetic prophylaxis by emetic risk
  • Immune checkpoint inhibitor toxicities
  • Growth factor support
  • Pain and palliative care
  • Safe handling and administration of cytotoxic drugs
Oncological Emergencies~7%6 topics
  • Metastatic spinal cord compression
  • Tumour lysis syndrome
  • Hypercalcaemia of malignancy
  • Superior vena cava obstruction
  • Hyperviscosity and leukostasis
  • Extravasation of vesicant drugs
Stem Cell Transplantation and Professional Practice~5%6 topics
  • Indications for autologous and allogeneic transplant
  • Graft-versus-host disease
  • Infection prophylaxis after transplant
  • Breaking bad news and shared decision making
  • Clinical trials, consent and ethics
  • Advance care planning

6 worked Haematology & Oncology practice questions

Original exam-style questions from the bank, spread across the blueprint domains. They are not real or recalled exam questions. Try each one, then open the answer for the rationale and reference. None of them appear in the free mock exam, so reading them will not spoil it.

  1. Question 1 · Haemoglobinopathies and Transfusion Medicine

    Two hours after receiving 3 units of red cells, an 82-year-old with heart failure becomes breathless with crackles, raised jugular venous pressure and blood pressure of 175/95 mmHg. Breathing improves after intravenous furosemide. What is the most likely diagnosis?

    1. ATransfusion-related acute lung injury
    2. BTransfusion-associated circulatory overload
    3. CAnaphylactic transfusion reaction
    4. DBacterial contamination of the unit
    Show answer and explanation

    Correct answer: B. Transfusion-associated circulatory overload

    Hypertension, raised venous pressure, positive fluid balance and response to diuretics in an older patient with heart failure point to transfusion-associated circulatory overload. TRALI is non-cardiogenic oedema, often with hypotension and fever, and does not respond to diuretics. Risk assessment and slower transfusion help prevent TACO.

    Reference: BSH Guideline on the investigation and management of acute transfusion reactions, 2023

  2. Question 2 · Haemostasis and Thrombosis

    A young woman with lifelong heavy periods and nosebleeds is diagnosed with type 1 von Willebrand disease. She needs a dental extraction. Which treatment is most often used to prevent bleeding in type 1 disease?

    1. ARecombinant factor IX
    2. BDesmopressin
    3. CPlatelet transfusion
    4. DVitamin K
    Show answer and explanation

    Correct answer: B. Desmopressin

    Desmopressin releases stored von Willebrand factor and factor VIII from endothelial cells and is effective in most patients with type 1 disease, ideally after a test dose shows a response. Tranexamic acid is useful for mucosal bleeding. Factor IX is for haemophilia B.

    Reference: James et al., ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease, Blood Adv 2021

  3. Question 3 · Lymphoid Malignancies and Plasma Cell Disorders

    A lymph node biopsy from a 22-year-old with cervical lymphadenopathy shows large binucleate cells with prominent nucleoli in a mixed inflammatory background. Which immunophenotype is typical of these cells in classical Hodgkin lymphoma?

    1. ACD20 and CD45 strongly positive
    2. BCD5 and CD23 positive
    3. CCD10 and BCL6 positive
    4. DCD15 and CD30 positive
    Show answer and explanation

    Correct answer: D. CD15 and CD30 positive

    Reed-Sternberg cells in classical Hodgkin lymphoma are typically CD30 and CD15 positive and usually CD45 negative. CD5 and CD23 co-expression is typical of chronic lymphocytic leukaemia. CD10 and BCL6 indicate a germinal centre B-cell phenotype.

    Reference: WHO Classification of Haematolymphoid Tumours, 5th ed.

  4. Question 4 · Lymphoid Malignancies and Plasma Cell Disorders

    A 62-year-old has an IgG paraprotein of 25 g/L, no anaemia, normal calcium and creatinine, and no lytic lesions. Which finding alone would establish multiple myeloma requiring treatment?

    1. ABone marrow clonal plasma cells of 15%
    2. BInvolved to uninvolved light chain ratio of 20
    3. CBone marrow clonal plasma cells of 65%
    4. DA single 3 mm focal lesion on MRI
    Show answer and explanation

    Correct answer: C. Bone marrow clonal plasma cells of 65%

    The IMWG criteria include myeloma-defining biomarkers: clonal marrow plasma cells of 60% or more, an involved to uninvolved free light chain ratio of 100 or more, or more than one focal lesion of at least 5 mm on MRI. Fifteen percent plasma cells without CRAB features or biomarkers is smouldering myeloma. A ratio of 20 does not meet the threshold.

    Reference: Rajkumar et al., IMWG updated criteria for the diagnosis of multiple myeloma, Lancet Oncol 2014

  5. Question 5 · Oncological Emergencies

    A man with bulky Burkitt lymphoma at high risk of tumour lysis syndrome is about to start chemotherapy. He has known G6PD deficiency. What is the best approach to uric acid control?

    1. ARasburicase at the standard dose
    2. BRasburicase at half the usual dose
    3. CIntravenous hydration with allopurinol
    4. DUrinary alkalinisation with bicarbonate alone
    Show answer and explanation

    Correct answer: C. Intravenous hydration with allopurinol

    Rasburicase is contraindicated in G6PD deficiency because the hydrogen peroxide it generates can cause severe haemolysis and methaemoglobinaemia. Aggressive hydration with allopurinol, close monitoring of electrolytes and renal function, and early access to dialysis are used instead. Urinary alkalinisation is no longer recommended.

    Reference: Jones et al., BSH Guidelines for the management of tumour lysis syndrome in adults and children, Br J Haematol 2015

  6. Question 6 · Red Cell Disorders and Anaemias

    A 32-year-old has haemolytic anaemia with a negative direct antiglobulin test, dark morning urine and a recent hepatic vein thrombosis. Which test confirms the most likely diagnosis?

    1. AOsmotic fragility test on red cells
    2. BHaemoglobin electrophoresis by HPLC
    3. CG6PD enzyme assay after recovery
    4. DFlow cytometry for GPI-anchored proteins
    Show answer and explanation

    Correct answer: D. Flow cytometry for GPI-anchored proteins

    Coombs-negative haemolysis, haemoglobinuria and thrombosis at an unusual site suggest paroxysmal nocturnal haemoglobinuria. Flow cytometry shows loss of GPI-anchored proteins such as CD55 and CD59 or FLAER binding on red cells and granulocytes. Osmotic fragility is used for hereditary spherocytosis.

    Reference: Borowitz et al., Guidelines for the diagnosis and monitoring of PNH by flow cytometry, Cytometry B Clin Cytom 2010

Haematology & Oncology reference books and guidelines

Every question in this bank names the textbook or guideline its answer rests on. These are the sources our Haematology & Oncology questions cite most often - the reading list to revise from alongside the bank.

Textbooks

1
  1. 1

    WHO Classification of Haematolymphoid Tumours

    5th edition

Guidelines and standards

10
  1. 1

    ESMO Clinical Practice Guideline: Early Breast Cancer

    2024
  2. 2

    BSH Guideline on the investigation and management of acute transfusion reactions

    2023
  3. 3

    BSH Significant haemoglobinopathies: guidelines for screening and diagnosis

    2010
  4. 4

    Society for Endocrinology Endocrine Emergency Guidance: Acute hypercalcaemia

    2016
  5. 5

    ESMO Clinical Practice Guideline: Metastatic Colorectal Cancer

    2023
  6. 6

    NICE Clinical Guideline: Ovarian cancer: recognition and initial management

    CG122
  7. 7

    NICE: Spinal metastases and metastatic spinal cord compression

    NG2342023
  8. 8

    BSH Guideline on the management of acute chest syndrome in sickle cell disease

    2015
  9. 9

    BSH Guideline for the laboratory diagnosis of iron deficiency in adults

    2021
  10. 10

    NICE Clinical Guideline: Neutropenic sepsis

    CG151

Where your regulator publishes a reading list, use the editions it names. Exam questions are not taken from any one book.

Last reviewed September 2026

About these questions: every question is original, researched by Neelim's exam research team, written to the published blueprint, with a rationale and a reference. No recalled or leaked exam content is used. How we write our questions.

Frequently asked questions

Are these real Haematology & Oncology exam questions?
No. Every item is original, researched by Neelim's exam research team against the exam blueprint published by the health authorities. Real, recalled or leaked exam content breaches the testing bodies' rules and can lead to a permanent exam ban - we do not sell it, and neither should anyone else.
How many questions are in the Haematology & Oncology bank?
Every bank starts at 3 full-length papers of roughly 150 questions each, the same length as the real computer-based exam, and you can add papers up to 6, including a bonus paper of our hardest questions. The papers do not overlap, so every question is new, and together they cover every sub-topic in the published blueprint.
How many attempts do I get?
In the UAE, three in total across DHA, DOH, MOHAP and SHA, not three each, under clause 1.5.4 of the Unified PQR (April 2025). Clause 1.5.5 allows one further attempt with a different authority, except on the Consultant route. Elsewhere in the GCC: SCFHS up to 4 a year, QCHP 5 per scope, OMSB no set maximum, Kuwait MOH 3, 6 weeks apart.
Which GCC regulators license the Haematology & Oncology title?
SCFHS sets a written exam (Saudi Classification Examination - Hematology and Oncology); QCHP sets a written exam (Specialist Haematology and Oncology). DOH licenses the title without a published written exam (credential review, interview or an unpublished assessment). DHA, MOHAP, SHA, NHRA, OMSB, Kuwait MOH publish no exam for this title. This bank prepares you for the written exams, and its content is the core knowledge any interview or assessment for the title draws on.
How do I receive it?
As PDF files. Card checkout is being set up, so for now you request it from this page and we send it to you directly, usually the same day.

Still unsure whether you even need this exam?

Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.